BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28624257)

  • 1. Moderate exercise training decreases inflammation in transgenic sickle cell mice.
    Charrin E; Dubé JJ; Connes P; Pialoux V; Ghosh S; Faes C; Ofori-Acquah SF; Martin C
    Blood Cells Mol Dis; 2018 Mar; 69():45-52. PubMed ID: 28624257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory and oxidative stress phenotypes in transgenic sickle cell mice.
    Charrin E; Ofori-Acquah SF; Nader E; Skinner S; Connes P; Pialoux V; Joly P; Martin C
    Blood Cells Mol Dis; 2016 Nov; 62():13-21. PubMed ID: 27835777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Individualized Treadmill Endurance Training on Oxidative Stress in Skeletal Muscles of Transgenic Sickle Mice.
    Gouraud E; Charrin E; Dubé JJ; Ofori-Acquah SF; Martin C; Skinner S; Chatel B; Boreau A; Messonnier LA; Connes P; Pialoux V; Hautier C; Faes C
    Oxid Med Cell Longev; 2019; 2019():3765643. PubMed ID: 31428225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischaemia-induced muscle metabolic abnormalities are poorly alleviated by endurance training in a mouse model of sickle cell disease.
    Chatel B; Messonnier LA; Vilmen C; Bernard M; Pialoux V; Bendahan D
    Exp Physiol; 2019 Mar; 104(3):398-406. PubMed ID: 30578584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic sickle mice have vascular inflammation.
    Belcher JD; Bryant CJ; Nguyen J; Bowlin PR; Kielbik MC; Bischof JC; Hebbel RP; Vercellotti GM
    Blood; 2003 May; 101(10):3953-9. PubMed ID: 12543857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endurance training reduces exercise-induced acidosis and improves muscle function in a mouse model of sickle cell disease.
    Chatel B; Messonnier LA; Barge Q; Vilmen C; Noirez P; Bernard M; Pialoux V; Bendahan D
    Mol Genet Metab; 2018 Mar; 123(3):400-410. PubMed ID: 29307759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does physical activity increase or decrease the risk of sickle cell disease complications?
    Martin C; Pialoux V; Faes C; Charrin E; Skinner S; Connes P
    Br J Sports Med; 2018 Feb; 52(4):214-218. PubMed ID: 26701924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel inflammatory role for platelets in sickle cell disease.
    Davila J; Manwani D; Vasovic L; Avanzi M; Uehlinger J; Ireland K; Mitchell WB
    Platelets; 2015; 26(8):726-9. PubMed ID: 25548984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
    Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
    Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of l-arginine supplementation associated with continuous or interval aerobic training on chronic heart failure rats.
    Barcelos GT; Rossato DD; Perini JL; Pinheiro LP; Carvalho C; Jaenisch RB; Rhoden CR; Lago PD; Nunes RB
    Metabolism; 2017 Nov; 76():1-10. PubMed ID: 28987235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of TGF-β1 in homeostasis of the inflammation in sickle cell disease.
    Torres Lde S; Okumura JV; da Silva DG; Belini Júnior É; de Oliveira RG; Mimura KK; Lobo CL; Oliani SM; Bonini Domingos CR
    Cytokine; 2016 Apr; 80():18-25. PubMed ID: 26928604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice.
    Holtzclaw JD; Jack D; Aguayo SM; Eckman JR; Roman J; Hsu LL
    Am J Respir Crit Care Med; 2004 Mar; 169(6):687-95. PubMed ID: 14684557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate-intensity endurance-exercise training in patients with sickle-cell disease without severe chronic complications (EXDRE): an open-label randomised controlled trial.
    Gellen B; Messonnier LA; Galactéros F; Audureau E; Merlet AN; Rupp T; Peyrot S; Martin C; Féasson L; Bartolucci P;
    Lancet Haematol; 2018 Nov; 5(11):e554-e562. PubMed ID: 30389037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease.
    Kalish BT; Matte A; Andolfo I; Iolascon A; Weinberg O; Ghigo A; Cimino J; Siciliano A; Hirsch E; Federti E; Puder M; Brugnara C; De Franceschi L
    Haematologica; 2015 Jul; 100(7):870-80. PubMed ID: 25934765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic morphological changes are accompanied by altered baseline immunity in a mouse model of sickle-cell disease.
    Szczepanek SM; McNamara JT; Secor ER; Natarajan P; Guernsey LA; Miller LA; Ballesteros E; Jellison E; Thrall RS; Andemariam B
    Am J Pathol; 2012 Nov; 181(5):1725-34. PubMed ID: 23000264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 Protein.
    Torres LS; Okumura JV; Silva DG; Mimura KK; Belini-Júnior É; Oliveira RG; Lobo CL; Oliani SM; Bonini-Domingos CR
    PLoS One; 2016; 11(11):e0165833. PubMed ID: 27802331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercoagulable state in sickle cell disease.
    Faes C; Sparkenbaugh EM; Pawlinski R
    Clin Hemorheol Microcirc; 2018; 68(2-3):301-318. PubMed ID: 29614638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell membrane and density changes under ambient and hypoxic conditions in transgenic mice producing human sickle hemoglobin.
    Reilly MP; Chomo MJ; Obata K; Asakura T
    Exp Hematol; 1994 Jun; 22(6):501-9. PubMed ID: 8187846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of arginine on oxidative stress in transgenic sickle mouse models.
    Dasgupta T; Hebbel RP; Kaul DK
    Free Radic Biol Med; 2006 Dec; 41(12):1771-80. PubMed ID: 17157180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Bone in Sickle Cell Trait and Sickle Cell Disease Female Mice Is Associated With Reduced IGF-1 in Bone and Serum.
    Xiao L; Andemariam B; Taxel P; Adams DJ; Zempsky WT; Dorcelus V; Hurley MM
    Endocrinology; 2016 Aug; 157(8):3036-46. PubMed ID: 27171384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.